Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Immunity Bio, Inc. Transaction History

Mitsubishi Ufj Kokusai Asset Management Co., Ltd.

$92.2 Billion
Q3 2024

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$2.68 - $6.14 $124,440 - $285,098	-46,433 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$5.05 - $7.53 $12,054 - $17,974	2,387 Added 5.42%	46,433 $260,000
Q4 2021 Feb 07, 2022	BUY	$5.67 - $10.18 $138,160 - $248,056	24,367 Added 123.82%	44,046 $332,000
Q2 2021 Aug 06, 2021	SELL	$13.41 - $22.4 $325,393 - $543,536	-24,265 Reduced 55.22%	19,679 $281,000
Q1 2021 May 06, 2021	BUY	$12.83 - $42.25 $563,801 - $1.86 Million	43,944 New	43,944 $1.04 Million

Others Institutions Holding IBRX

# of Institutions

204

Shares Held

70M

Call Options Held

1.68M

Put Options Held

1.31M

View Full List

About ImmunityBio, Inc.

Ticker IBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 400,304,000
Market Cap $1.05B
Description
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...

More about IBRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Kokusai Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mitsubishi Ufj Kokusai Asset Management Co., Ltd. with notifications on news.

Account